These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25798057)
1. Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer. Shen XJ; Zhang H; Tang GS; Wang XD; Zheng R; Wang Y; Zhu Y; Xue XC; Bi JW Int J Biol Sci; 2015; 11(4):370-9. PubMed ID: 25798057 [TBL] [Abstract][Full Text] [Related]
2. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. Simpkins SA; Hanby AM; Holliday DL; Speirs V J Pathol; 2012 Aug; 227(4):490-8. PubMed ID: 22488553 [TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer. Zhao X; He Y; Gao J; Fan L; Li Z; Yang G; Chen H PLoS One; 2013; 8(3):e59102. PubMed ID: 23527097 [TBL] [Abstract][Full Text] [Related]
4. Paeoniflorin Inhibits Migration- and Invasion-Promoting Capacities of Gastric Cancer Associated Fibroblasts. Wang ZF; Ma DG; Wang L; Feng L; Fu JW; Li Y; Wang DT; Jia YF Chin J Integr Med; 2019 Nov; 25(11):837-844. PubMed ID: 30361813 [TBL] [Abstract][Full Text] [Related]
5. Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. He Y; Zhao X; Gao J; Fan L; Yang G; Cho WC; Chen H Int J Mol Sci; 2012 Oct; 13(11):13764-80. PubMed ID: 23203033 [TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts. Wang ZF; Ma DG; Zhu Z; Mu YP; Yang YY; Feng L; Yang H; Liang JQ; Liu YY; Liu L; Lu HW World J Gastroenterol; 2017 Dec; 23(48):8512-8525. PubMed ID: 29358859 [TBL] [Abstract][Full Text] [Related]
7. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Martinez-Outschoorn UE; Pavlides S; Whitaker-Menezes D; Daumer KM; Milliman JN; Chiavarina B; Migneco G; Witkiewicz AK; Martinez-Cantarin MP; Flomenberg N; Howell A; Pestell RG; Lisanti MP; Sotgia F Cell Cycle; 2010 Jun; 9(12):2423-33. PubMed ID: 20562526 [TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Trimmer C; Sotgia F; Whitaker-Menezes D; Balliet RM; Eaton G; Martinez-Outschoorn UE; Pavlides S; Howell A; Iozzo RV; Pestell RG; Scherer PE; Capozza F; Lisanti MP Cancer Biol Ther; 2011 Feb; 11(4):383-94. PubMed ID: 21150282 [TBL] [Abstract][Full Text] [Related]
9. Differential expression and function of caveolin-1 in human gastric cancer progression. Burgermeister E; Xing X; Röcken C; Juhasz M; Chen J; Hiber M; Mair K; Shatz M; Liscovitch M; Schmid RM; Ebert MP Cancer Res; 2007 Sep; 67(18):8519-26. PubMed ID: 17875691 [TBL] [Abstract][Full Text] [Related]
10. Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts. Wang Z; Ma D; Wang C; Zhu Z; Yang Y; Zeng F; Yuan J; Liu X; Gao Y; Chen Y; Jia Y Biomed Pharmacother; 2017 Dec; 96():757-767. PubMed ID: 29049979 [TBL] [Abstract][Full Text] [Related]
12. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330 [TBL] [Abstract][Full Text] [Related]
13. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments. Kinoshita H; Yashiro M; Fukuoka T; Hasegawa T; Morisaki T; Kasashima H; Masuda G; Noda S; Hirakawa K Carcinogenesis; 2015 Dec; 36(12):1511-20. PubMed ID: 26385890 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Martinez-Outschoorn UE; Balliet RM; Rivadeneira DB; Chiavarina B; Pavlides S; Wang C; Whitaker-Menezes D; Daumer KM; Lin Z; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Knudsen ES; Sotgia F; Lisanti MP Cell Cycle; 2010 Aug; 9(16):3256-76. PubMed ID: 20814239 [TBL] [Abstract][Full Text] [Related]
15. The expression and functionality of stromal caveolin 1 in human adenomyosis. Zhao L; Zhou S; Zou L; Zhao X Hum Reprod; 2013 May; 28(5):1324-38. PubMed ID: 23442759 [TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells. Matsui T; Higashimoto Y; Taira J; Yamagishi S Biochem Biophys Res Commun; 2013 Nov; 441(2):405-10. PubMed ID: 24161393 [TBL] [Abstract][Full Text] [Related]
17. A novel actin cytoskeleton-dependent noncaveolar microdomain composed of homo-oligomeric caveolin-2 for activation of insulin signaling. Kwon H; Lee J; Jeong K; Jang D; Pak Y Biochim Biophys Acta; 2013 Oct; 1833(10):2176-89. PubMed ID: 23665048 [TBL] [Abstract][Full Text] [Related]
18. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Pavlides S; Tsirigos A; Vera I; Flomenberg N; Frank PG; Casimiro MC; Wang C; Fortina P; Addya S; Pestell RG; Martinez-Outschoorn UE; Sotgia F; Lisanti MP Cell Cycle; 2010 Jun; 9(11):2201-19. PubMed ID: 20519932 [TBL] [Abstract][Full Text] [Related]
19. Bidirectional alteration of Cav-1 expression is associated with mitogenic conversion of its function in gastric tumor progression. Ryu BK; Lee MG; Kim NH; Lee KY; Oh SJ; Moon JR; Kim HJ; Chi SG BMC Cancer; 2017 Nov; 17(1):766. PubMed ID: 29141593 [TBL] [Abstract][Full Text] [Related]
20. Differences in the expression of caveolin-1 isoforms in cancer-associated and normal fibroblasts of patients with oral squamous cell carcinoma. Kaya S; Wiesmann N; Goldschmitt J; Krüger M; Al-Nawas B; Heider J Clin Oral Investig; 2021 Oct; 25(10):5823-5831. PubMed ID: 33774714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]